Investigators designed and externally validated a prostate cancer death prediction model for risk stratification of men at the point of PSA screening.
A newly developed long-term prediction model demonstrated greater accuracy in estimating prostate cancer–specific mortality compared with existing risk assessment tools. Unlike traditional ...